EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Sepsis

Ghazan Askar

NORTHWEST JOURNAL OF MEDICAL SCIENCES · 2022

DOI: 10.69723/njms.01.02.0301 ↗
AbstractBibliografische Angaben

Abstract

Around 5 million or 50% of all hospital fatalities globally are caused by sepsis, making it one of the top causes of unnecessary mortality in global health care systems.1Today, it is recognized that sepsis is a condition that must be diagnosed quickly and treated effectively. As a result, the most recent consensus conference identified septic shock as a subtype of sepsis in which the underlying metabolic and circulatory abnormalities are severe enough to dramatically raise mortality. A life-threatening organ malfunction known as sepsis is caused by an unbalanced host response to infection. The amount of sepsis cases that present outside of an ICU has significantly increased since the start of the 2000s. The majority of research and treatment regimens for sepsis originated in ICU settings, and intensivists were in charge of managing it for many years. Sepsis requires timely identification and a consistent approach for an effective treatment because it is a time-dependent illness. The absence of traditional infection symptoms (such as fever) in general medicine wards is one of the primary obstacles to this goal.2 A completely new strategy and awareness are required when approaching a suspected septic patient with quick recognition and standardized best therapy because the disease is now showing up in the general medicine ward environment.3 Different disease treatment modalities have been developed in response to the disease's varied appearance. Innovative methods for lowering the death rate from severe sepsis have recently come to light. Some of the newer methods include the use of low tidal volumes, median corticosteroid dosages, aggressive plasma glucose management in ARDS, emergency services, central venous pressure monitoring, hourly urine output, and central venous oxygen saturation. According to conventional wisdom, corticosteroids have a deleterious impact on the clinical course of sepsis and are well recognized to cause secondary infections as a result of the immunosuppressive effects they have when taken in high doses to treat sepsis. Yet, it was shown that when taken cautiously, they reduced the death rate. The use of a combination of vitamins (such vitamin C and vitamin D) and probiotics to treat sepsis is currently receiving a lot of attention. According to studies, oral Lactobacillus probiotics with vitamin D and vitamin C both increased survival and lowered the risk of sepsis in trauma patients. Another cutting-edge strategy for treating sepsis patients is the use of fibrates (fenofibrates), which are triglyceride-reducing medicines with antioxidant and anti-inflammatory characteristics due to activation of peroxisome proliferator-activated receptor alpha. In trials on sepsis, fenofibrate treatment was reported to reduce fatality rates by 12.5%.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →